Materials / Industrial MaterialsUpdated 2026-05-10 22:07 UTC

LON/0NHS stock hub

LON/0NHS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0NHSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24.1B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0NHS

In the news

Latest news · LON/0NHS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.5

P25 9.2P50 12.8P75 17

Trailing P/E13.3

P25 13P50 18.3P75 31.1

ROE9.8

P25 -25P50 -5.2P75 12.4

ROIC7.3

P25 -12.3P50 -1.5P75 11

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0NHS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

USD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	UK
Employees	25,500
Employees Change	-400%
Employees Change Percent	-1.54
Enterprise value	$33.9B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Industrial Materials
Isin	CA67077M1086
Last refreshed	2026-05-10
Market cap	$24.1B
Price	$68.74
Price currency	USD
Rev Per Employee	798,199.47x
Sector	Materials
Sic	2870
Symbol	lon/0NHS
Website	https://www.nutrien.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.51%
EV Earnings	18.78x
EV/EBIT	12.42x
EV/EBITDA	7.49x
EV/FCF	19.01x
EV/Sales	1.69x
FCF yield	7.42%
Forward P/E	11.48x
P/B ratio	1.26x
P/E ratio	13.31x
P/S ratio	1.18x
PE Ratio10 Y	34.86x
PE Ratio3 Y	23.66x
PE Ratio5 Y	19.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.46%
EBITDA Margin	20.82%
FCF margin	8.77%
Gross margin	32.27%
Gross Profit	$6.6B
Gross Profit Growth	18.6%
Gross Profit Growth Q	24.7%
Gross Profit Growth3 Y	-14.91%
Gross Profit Growth5 Y	9.5%
Net Income	$1.8B
Net Income Growth	352.94%
Net Income Growth Q	1,090.91%
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	-29.64%
Net Income Growth5 Y	30.9%
Pretax Margin	11.85%
Profit Margin	8.88%
Profit Per Employee	$70,890
Profitable Years	14
ROA	4.23
Roa5y	5.88
ROCE	8.91
ROE	9.81
Roe5y	12.38
ROIC	7.32
Roic5y	9.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	24.8%
Cagr3y	6.07%
Cagr5y	6.74%
Div CAGR3	-0.88%
Div CAGR5	3.28%
EPS Growth	363.8
EPS Growth Q	1,250
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth3 Y	-27.63
EPS Growth5 Y	35.2
FCF Growth	139.15%
FCF Growth3 Y	-22.11%
FCF Growth5 Y	0.68%
OCF Growth	44.15%
OCF Growth10 Y	7.77%
OCF Growth3 Y	-16.63%
OCF Growth5 Y	2.77%
Revenue Growth	8.64x
Revenue Growth Q	19.04x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	-8.83x
Revenue Growth5 Y	5.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.5
Assets	$40.8B
Cash	$588.4M
Current Assets	$12.1B
Current Liabilities	$9.8B
Debt	$10.6B
Debt EBITDA	$2.32
Debt Equity	$0.55
Debt FCF	$5.91
Equity	$19.1B
Interest Coverage	5.38
Liabilities	$21.8B
Long Term Assets	$28.8B
Long Term Liabilities	$12B
Net Cash	$-10B
Net Cash By Market Cap	$-41.45
Net Debt EBITDA	$2.35
Net Debt Equity	$0.52
Net Debt FCF	$5.58
Tangible Book Value	$8.6B
Tangible Book Value Per Share	$17.89
WACC	8.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.24
Inventory Turnover	2.18
Net Working Capital	$5B
Quick ratio	0.53
Working Capital	$2.4B
Working Capital Turnover	$6.85

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.73%
Dividend Growth	-3.48%
Dividend Growth Years	0%
Dividend per share	$1.62
Dividend Years	9
Dividend Yield	2.36%
Ex Div Date	2026-03-31
Last Dividend	$0.42
Payout Frequency	Quarterly
Payout Ratio	44.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	24.78%
200-day SMA	64.24
3Y total return	19.35%
50-day SMA	74.87
50-day SMA vs 200-day SMA	50over200
5Y total return	38.58%
All Time High	114.2
All Time High Change	-39.81%
All Time High Date	2022-04-20
All Time Low	28.2
All Time Low Change	143.77%
All Time Low Date	2020-03-13
ATR	3.25
Beta	1.1
Ch YTD	11.46
High	70.19
High52	87.36
High52 Date	2026-03-13
High52ch	-21.31%
Low	68.1
Low52	53.05
Low52 Date	2025-11-04
Low52ch	29.59%
Ma50ch	-8.18%
Price vs 200-day SMA	7%
RSI	38.81
RSI Monthly	57.39
RSI Weekly	50.35
Sharpe ratio	0.79x
Sortino ratio	1.35
Total Return	4.09%
Tr YTD	12.27
Tr1m	-10.78%
Tr1w	-8.65%
Tr3m	1.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$2.7B
Operating Income Growth	50.06
Operating Income Growth Q	64.63
Operating Income Growth3 Y	-25.46
Operating Income Growth5 Y	15.61
Operating margin	13.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	479,320,500%
Net Borrowing	-872,881,660
Shares Insiders	0.04%
Shares Institutions	78.35%
Shares Qo Q	-0.33%
Shares Yo Y	-1.73%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.6B
Average Volume	8,766.9x
Bv Per Share	39.62
CAPEX	$-1.4B
Ch1m	-10.79
Ch1w	-8.65
Ch1y	20.54
Ch3m	0.6
Ch3y	6.26
Ch5y	17.29
Ch6m	22.03
Change	0.03%
Change From Open	0.2
Close	68.72
Days Gap	-0.17
Depreciation Amortization	1,450,157,178
Dollar Volume	627,871.2
Earnings Date	2026-05-06
EBIT	$2.7B
EBITDA	$4.2B
EPS	$3.73
F Score	8
FCF	$1.8B
FCF EV Yield	5.26x
Financing CF	-2,087,132,580
Fiscal Year End	December
Founded	2,017
Goodwill	8,931,266,464
Graham Number	79.58926
Graham Upside	15.78
Income Tax	$582.4M
Investing CF	-1,223,804,880
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Lynch Fair Value	$129
Lynch Upside	87.84
Ma150	66.4
Ma150ch	3.53%
Ma20	72.97
Ma20ch	-5.8%
Net CF	-79,517,025
Next Earnings Date	2026-08-06
Open	68.6
P FCF Ratio	13.47
P OCF Ratio	7.5
Payment Date	2026-04-16
Position In Range	30.62
Ppne	16,620,693,726
Price Date	2026-05-08
Price EBITDA	$5.68
Ptbv Ratio	2.8
Relative Volume	1.12x
Revenue	20,354,086,485x
SBC By Revenue	0.88x
Share Based Comp	179,481,285
Tax By Revenue	2.86x
Tax Rate	24.14%
Tr6m	23.99%
Volume	9,134
Z Score	1.72

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0NHS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.4%

$1.62 annual per share

Payout ratio

+44.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.3%

0 consecutive years of growth

Total shareholder yield

+4.1%

Next ex-dividend date: 2026-03-31

Performance

LON/0NHS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0NHS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+78.3%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.7%

Negative means the company is buying back shares.

Technical

LON/0NHS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.8

Neutral momentum band

Price vs 200-day MA

+7.0%

50/200-day relationship not available

Beta (5Y)

1.09

Moves roughly with the market

Sharpe ratio

0.79

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0NHS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0NHS stock rating?

lon/0NHS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0NHS analysis?

The full report lives at /stocks/lon/0NHS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0NHS?

The latest report frames lon/0NHS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0NHS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.